CADRENAL THERAPEUTICS INC (CVKD) Stock Earnings Estimates

NASDAQ:CVKD • US1276362076

5.42 USD
-0.28 (-4.91%)
Last: Feb 12, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
CVKD revenue by date.CVKD revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
CVKD ebitda by date.CVKD ebitda by date.
N/A-2.7M-7.631M
-182.62%		-10.959M
-43.61%		N/A
-58.23%		N/A
-22.94%		N/A
-44.50%		N/A
-22.85%		N/A
EBIT
YoY % growth
CVKD ebit by date.CVKD ebit by date.
-2.7M-7.633M
-182.70%		-10.961M
-43.60%		N/A
-19.12%		N/A
14.06%		N/AN/A
-237.27%		N/A
347.61%
Operating Margin
CVKD operating margin by date.CVKD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CVKD eps by date.CVKD eps by date.
N/AN/AN/A-8.67
6.34%		N/A
62.15%		N/A
99.32%		N/A
172.73%		N/A
-19,725.00%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.23
54.96%		-1.36
35.09%		-1.42
24.18%		-1.54
-17.57%		-1.25
-1.65%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-4.794M
-12.10%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.448M
42.78%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -1.31
39.91%		-1.560.2515.87%
Q2 2025
Q2Q % growth		 -1.87
16.89%		-1.63-0.24-14.82%
Q1 2025
Q2Q % growth		 -2.09
-39.33%		-1.67-0.42-24.94%
Q4 2024
Q2Q % growth		 -2.74
-265.33%		-1.75-0.99-56.79%
Q3 2024
Q2Q % growth		 -2.18 -1.97-0.21-10.93%
Q2 2024
Q2Q % growth		 -2.25 -1.30-0.95-73.01%
Q1 2024
Q2Q % growth		 -1.50 -1.07-0.43-40.06%
Q4 2023
Q2Q % growth		 -0.75 -1.300.5542.33%
CVKD Yearly EPS VS EstimatesCVKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CVKD Yearly Revenue VS EstimatesCVKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2.54% 23.9% 52.53% 54.37%
RevenueN/A N/A N/A N/A